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Summary
Mycobacteria elicit a cellular immune response in their hosts. This response usually leads to protective
immunity, but may sometimes be accompanied by immunopathology due to delayed type
hypersensitivity (DTH) . A striking example in man is tuberculoid leprosy, which is characterized
by high cellular immunity to Mycobacterium leprae and immunopathology due to DTH. Skin
lesions of patients suffering from this disease have the characteristics ofDTH reactions in which
macrophages and CD4+ T lymphocytes predominate . In animal models, it has been shown that
DTH responses are associated with the presence of a particular subset ofCD4+ T cells (T helper
type 1 [Thl]) that secrete only certain cytokines, such as interleukin 2 (1112), interferon y (IFN-
7), and lymphotoxin, but no IIJ4 or 1L5 . We studied the cytokine release of activatedM . lep-
rae-reactive CD4+ T cell clones derived from tuberculoid leprosy patients . These T cell clones,
which were reactive with mycobacterial heat shock proteins, exhibited a Thl-like cytokine secretion
pattern with very high levels ofIFN-y . Half of these clones secreted low levels of IL-4 and 11,5,
but the ratio of IFN-y to IL-4 and 11,5 was much higher than that of T cell clones reactive
with nonmycobacterial antigens . A Thl-like cytokine secretion pattern was also observed for
T cell clones and polyclonalT cell lines from control individuals that recognized both heat shock
and other mycobacterial antigens. The levels of IFN-y secreted by these clones were, however,
significantly less than those of patient-derived T cell clones. This Thl-like pattern was not found
withT cell clones from the same patients and healthy individuals generated in the same manner,
but reactive with nonmycobacterial antigens. Our data thus indicate that mycobacteria selectively
induce human T cells with a Thl-like rytokine secretion profile .
Activated murine CD4+ T cells comprise at least two
AU functionally distinct subsets of cells (1, 2) : Thl cells
that secrete 11,2 and IFN-y upon activation but not 114 or
IL5, and Th2 cells that produce IL4 and IL5 but not IL2
orIFN-y . The differential cytokine secretion profile of these
CD4+ T cells correlates with different effector functions ex-
erted by these cells : Thl cells mediate delayed type hypersen-
sitivity (DTH)t responses (3, 4), and Th2 cells provide su-
perior help for antibody production by B cells (5, 6) . There
is some support for the notion that Thl and Th2 cells are
progeny ofTh0 cells, which can produce IL-2, IFN-y, IL4,
and 116 simultaneously (7-10) .
Human T cell clones, so far, can not be classified into Thl
I Abbreviations used in thispaper: DTH, delayed-type hypersensitivity; GM,
granulocyte/macrophage; NIP, nitro-iodophenyl; PPD, purified protein
derivative ; RT, room temperature .
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and Th2 cell types. MostT cell clones obtained from healthy
subjects were able to produce IL2, IFN-y, IL4, and 1175 simul-
taneously after activation (11) . This rytokine secretion profile
was observed with randomly isolatedT cell clones upon stim-
ulation with mitogens, but was also found for alloreactive
and tetanus toxoid-specific clones after stimulation with
specific antigen . These findings suggest that most humanT
cell clones are comparable to murineTh0 cells. Recently, how-
ever, we observed that a series ofT cell clones isolated from
a patient suffering from severe combined immune deficiency
(SCID) that was successfully transplanted with fetal tissue
were unable to produce IL4 upon activation, while normal
levels of IL2, IFN-y, and IL5 were detected in the superna-
tants of these clones (12) . These findings indicated that in
man also, CD4+ T cell clones can emerge that display selec-
tive rytokine secretion profiles. Support for this notion was
provided by results from Wierenga et al . (13), who described
that CD4+ T cell clones from atopic patients that were
J. Exp. Med . ® The Rockefeller University Press " 0022-1007/91/09/0583/10 $2.00
Volume 174 September 1991 583-592specific for a crude extract of house dust mite secreted IL4
but undetectable levels ofIFN-y . These cells may be thehuman
analogue ofmouseTh2 cells. Thus far, however, human Th1
cells have not been observed.
It may be expected to findTh1 type cells or inflammatory
T cells in those diseases that are characterized byT cell-medi-
ated inflammations, the best candidates being infectious dis-
eases, like leprosy and tuberculosis, that are caused by mycobac-
teria . These pathogens are known to elicit strong T cell-
mediated immune responses sometimes accompanied byDTH
reactions and granuloma formation. These features are typ-
ical for tuberculoid leprosy, a disease caused by Mycobacterium
leprae (14) . In the granulomatous skin lesions of patients
suffering from tuberculoid leprosy, macrophages and CD4+
T lymphocytes predominate. It is thought that these CD4+
T cells and their secreted products are responsible for some
of the features of the disease, like severe DTH responses . In
the present study, we have investigated the cytokine secre-
tion patterns ofM. leprae-reactive T cell clones from tuber-
culoid leprosy patients and compared these patterns with those
obtained from control individuals, also reactive with mycobac-
terial protein antigens. Both sets of mycobacteria-reactive T
cell clones display a Th1-like pattern of cytokine release; after
activation, many of these clones secreted (excessively) high
levels ofIFN-,y, while levels ofIL4 and IL-5 varied from normal
to undetectable. This Th1-like pattern appeared to be specific
for T cells reactive with mycobacterial antigens, because T
cell clones from the same individuals reactive with non-
mycobacterial antigens displayed a ThO-like profile with normal
levels of IL4 and IL-5 .
Material and Methods
Antigens. M. leprae (CD104) was a kind gift ofDr.R .J .W . Rees
(National Institute for Medical Research, London, UK) . Hsp65
peptides amino acids 3-13, 418-427, and 412-425 were made by
a solid phase peptide synthesis methodology and checked using an-
alytical reverse phaseHPLC and amino acid analysis (15) . The pep-
tides were kindly provided by Dr. D.C. Anderson (University of
Washington, Seattle, WA) . Purified protein derivative (PPD) was
obtained from the Statens Seruminstitut (Copenhagen, Denmark),
M . tuberculosis ultrasonicate preparation (H37RA) was kindly do-
nated by Dr. P. Klatser from the Royal Tropical Institute (Am-
sterdam, The Netherlands), and tetanus toxoid was obtained from
the National Institute ofPublic Health and Environmental Protec-
tion (Bilthoven, The Netherlands) .
T Cell Clones and Lines.
￿
T cell clones were prepared as described
previously . Briefly, 106 PBL from tuberculoid leprosy patients (16),
healthy individuals (17), and rheumatoid arthritis patients (18) were
incubated withM. leprae, hsp65 peptide 3-13, tetanus toxoid, or
PHA (Wellcome Diagnostics, Dartford, UK) for 5 d in IMDM
(Gibco Laboratories, Paisley, Scotland) supplemented with 10%
human serum (HS) or in Yssel's medium (19) . The respondingT
cell blasts were expanded on IL2 (kindly provided by Dr. R .
Kastelein, DNAX, Palo Alto, CA). These activated T cells were
then cloned by limiting dilution technique (0.3 cell/well) in 96-
well flat-bottomed plates (Linbro ; Flow Laboratories, McLean, VA)
in the presence ofa feeder cell mixture consisting ofirradiated (30
Gy) allogeneic PBL (106/ml) and irradiated (50 Gy) EBV
transformed B cells (105/ml) and antigen . The clones were main-
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tained in culture in the presence of11,2 and wererestimulatedweekly
with the feeder cell mixture containing also 0.1-1.0 jag/ml PHA
(Wellcome Diagnostics) . AllT cell clones used in this study were
CD4+ . The polyclonal T cell lines were generated by in vitro re-
stimulation ofPBMC with PPD orM. leprae for 5 d . Thereafter,
the responding T cell blasts were expanded to large numbers by
addition of exogenous rIL2 (20 U/ml) to the cultures for another
7 d. The antigen specificity ofthe mycobacteria-reactive T cell clones
and lines was tested using T cell immunoblot analysis (20, 21),
as described in reference 18, and byJanson et al . (manuscript sub-
mitted for publication) .
StimulationforLymphokine Secretion.
￿
The T cell clones and lines
were stimulated for lymphokine secretion 8-12 d after the last stim-
ulation with feeder cells . At that time point no feeder cells were
present . In addition, T cells at this stage did not produce IL2, 114,
or IFN-y spontaneously (11) . The cells were washed twice with
medium and placed in 1-ml volumes at a concentration of 106
cells/ml in Linbro 24-well tissue culture plates (Flow Laboratories) .
Polyclonal stimulation wasperformed using 20 kg/ml ConA (Sigma
Chemical Co ., St . Louis, MO) or with a 1:3,000 dilution of anti-
CD3 mAb (ascites SPVT3b) (11) plus 1 ng/mlPMA (Sigma Chem-
ical Co.) . The antigen-specific stimulation was performed using
autologous or HLADR-matched APC (3-5 x 106/ml) with an
optimal dose of antigen . T cells and APC alone were used as con-
trols . The cultures were incubated at 37°C in a humidified at-
mosphere with 5% COZ for 20-24 h . The supernatants were har-
vested and stored immediately at -20°C and thawed before testing.
Cytokine Detection Assays.
￿
11,2 activity was assayed on the mu-
rine IIL2-dependent cell line CTLL2, as described by Gillis et al .
(22) . The activity of the supernatants was compared with that of
a standard 11,2 and calculated according to Gillis et al . (22) . 11,4,
IL-5, IFN-y, and granulocyte/macrophage (GM)-CSF were quan-
tified with immunoenzymatic assays (11, 12, 23) that were per-
formed as follows . PVC plates (Nunc, Roskilde, Denmark) were
coated with 10,ug/ml antibody (IIA:rabbit IgG anti-IL4 antiserum;
IL5.JES1-39D10 .1 ; IFN-y:3-6 ; GM-CSF:23B6.4) and incubated for
2 h at 37°C . The plates were washed in an automatic washer
(Titertek, Flow Laboratories, Irvine, Scotland) with PBS sup-
plemented with 0.1% BSA (Sigma Chemical Co.) and 0.5%
Tween 20 (Sigma Chemical Co .) . Standard recombinant lympho-
kines (IL4, IL-5, IFN-y, and GM-CSF, kindly provided by R .
Kastelein [DNAX]) were diluted in medium, and theT cell super-
natants were added to the plates and incubated at room tempera-
ture (RT) for 2 h . After three washes, a second antibody coupled
to nitro-iodophenyl (NIP) was added (IL4 : 25D2.11-NIP ; I1L5 :JES1-
5A10-NIP; IFN-y : B27-NIP; GM-CSF: 21C11.3-NIP) . The plates
were incubated for 1 h at RT . After three washes, HR-peroxidase
coupled to an anti-NIP antibody (14) was added and the plates were
incubated for another 1 h at RT. Enzymatic activity was deter-
mined with the substrate 2.2' amino bis-3-ethyl-benzthiozohn sul-
fonic acid(AIM) (Sigma Chemical Co.) . The plates were read with
aVmax microplate reader (Molecular Devices, Redwood City, CA)
coupled to a computer. Data were analyzed using specific software
(Molecular Devices, Redwood City, CA) .
Results
Lymphokine Secretion Profile ofT Cell Clonesfrom a Tuber-
culoid Leprosy Patient. M. leprae-reactive CD4+ T cell clones
were obtained from tuberculoid (TT) leprosy patient R . The
antigen specificity and theHLADR restriction has been de-
termined and described previously (24, 25) . TheT cell clones
recognized either the mycobacterial 65AD heat shock pro-tein (hsp65) (26), or another protein (Mr = 67-80 kD hsp
ofM . leprae), as determinedby immunoblottechnique Oanson
et al., manuscript submitted for publication), and were re-
stricted by HLADR2 or DR3. The T cell epitopes within
hsp65 were mapped recently (26) . The HLA-DR2-restricted
clones recognize an M. leprae-specific epitope (amino acids
418-427, LQAAPALDKL). The majority of the HLADR3-
restricted T cell clones recognizes an epitope on the NH2
terminus ofhsp65 (amino acids 3-13, KTIAYDEEARR) that
is immunodominant for HLADR3-restricted hsp65-reactive
T cells (27); two other clones were reactive with another
hsp (Mr = 67-80 kD). Clones that recognize the same epi-
tope restricted by the same HLADR molecule can use different
TCRs as determined by Southern blot analysis and VO gene
segment sequencing (van Schooten et al., manuscript sub-
mitted for publication).
To analyze the cytokine secretion profile (IFN-y, 11,2, IL4,
and 11,5) of these T cell clones, the cells were stimulated with
APC and the appropriate antigen. As a source of antigen,
we used synthetic peptides corresponding to the T cell epi-
topes of hsp65 in case of hsp-65-specific clones, or M . leprae
for clones RIE4 and R1F3. Upon stimulation with antigen,
most M . leprae-reactive clones from this TT leprosy patient
secreted high levels of IFN-y, and some clones showed ex-
tremely high IFN-y secretion (>1,000 ng/ml) . In contrast,
the levels of 11,4 and 11,5 produced by these clones were ei-
ther undetectable, low, or in the normal range (Table 1). In
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those supernatants where normal levels ofIL4 and IL5 were
detected, the levels of IFN-y were very high, resulting in
IFN-y to IL4 ratios (96-28,000) that were disproportionate
compared to such ratios detected in the supernatants ofmost
normal T cell clones. These normal values for secretion of
IFN-y, 114, and 1175 were obtained by screening a large panel
(n = 38) of CD4+ T cell clones isolated from four healthy
individuals. We measured the ratio of IFN-y to IL4 secre-
tion as a marker for Th cytokine secretion profiles. The an-
tigen specificity of the T cell clones varied, including tetanus
toxoid and HLA class II alloantigens, but no mycobacterial
antigens were recognized. Mean values for IFN-y secreted
upon stimulation with Con A or specific antigen ranged from
3 to 54 ng/ml, for IL-4 from 200 to 3,200 pg/ml, and the
IFN-y to 111,4 ratios varied from 1 to 62. These ratios are
included in Fig. 1, where we compare ratios of IFN-y to
IL4 secretion between all T cellsreactive with nonmycobac-
terial antigens used in this study. When measured, the level
of1172 and GM-CSF secretion by these clones was comparable
to those observed with tetanus toxoid and alloreactive clones
from healthy individuals (data not shown). Importantly, the
same Thl-like cytokine secretion pattern with excessive high
levels of IFN-y and undetectable to normal levels of IL4 and
IL-5 was observed for five DRl-restricted, hsp65-specific T
cell clones from two other tuberculoid leprosy patients (data
included in Fig. 1).
To investigate whether the Thl-like cytokine secretion pat-
Table 1.
￿
Cytokine Secretion Profiles T Cell Clones reactive with Mycobacterial hsp and Nonmycobacterial Antigens from Tuberculoid
Leprosy Patient R
Donor Clone Restricted by: Specificity IFN-y IL-4 IL-5
Ratio of
IFN-y/IL-4
ng/ml pg/ml pg/ml
R 2F10 HLA-DR2 [418-427] 1,300.0 ± 78 1,080 ± 38 965 ± 46 1,203
2B61 HLA-DR2 [418-427] 99.2 ± 22 370 ± 100 <50 268
1F9 HLA-DR3 [3-13] 1,400.0 ± 42 <50 <50 >28,000
3E10 HLA-DR3 [3-131 77.5 ± 2 <50 <50 >1,550
5E10 HLA-DR3 [3-13] 48 .9 ± 6 <50 <50 >978
515 HLA-DR3 [3-131 192 .4 ± 24 1,995 ± 415 <50 96
518 HLA-DR3 [3-13] 1,100.0 ± 54 2,110 ± 130 >5,000 521
IE4 HLA-DR3 hsp 67-80 kD 5 .9 ± 2 <50 <50 >118
1F3 HLA-DR3 hsp 67-80 kD 44.3 ± 1 <50 <50 >886
R TT003 HLA-DR2,3 Tet . tox. 1 .4 ± 1 3,600 ± 310 1,175 ± 240 0.4
TT004 HLA-DR2,3 Tet . tox. 10.2 ± 1 1,100 ± 220 2,375 ± 210 9.3
TT005 HLA-DR2,3 Tet . tox 6 .4 ± 1 2,000 ± 100 ND 3.2
TT006 HLA-DR2,3 Tet . tox 3 .6 ± 1 4,300 ± 100 ND 0.8
TT008 HLA-DR2,3 Tet . tox 3 .4 ± 1 1,650 ± 100 ND 2.1
TT011 HLA-DR2,3 Tet . tox 37 .0 ± 1 2,400 ± 100 ND 15.4
TT014 HLA-DR2,3 Tet . tox 20.0 ± 1 5,000 ± 200 ND 4
A101 ND JY 6.3 ± 1 270 ± 40 6,230 ± 310 23
A109 ND JY 28 .2 ± 1 165 ± 40 835 ± 175 34Figure 1 .
￿
(0)T cell clones reactive with mycobacterial hsp antigens;
(O) T cell clones reactive with mycobacterial non-hsp antigens ; (0) poly-
clonalT cell lines reactive with mycobacterial non-hsp antigens; (0) T
cell clones reactive with nonmycobacterial antigens, including tetanus toxoid
and allo-antigens. The IFN--y to I1r4 ratios of the majority of the T cells
reactive with mycobacterial antigens are higher than the depicted values
(see Tables 1, 2, and 3) .
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terns we observed were related to recognition of mycobac-
terial antigens, we also analyzed the cytokine secretion profiles
of anumber of alloreactive and tetanus toxoid-specificT cell
clones from tuberculoid leprosy patientR . In the superna-
tants ofeight tetanus toxoid-specific and two alloreactive clones
from this patient, we detected moderate levels of IFN-y, 11,4,
and IL5, all within the normal range . Also, the IFN-y to
11,4 ratios, varying from 0.4 to 34, are clearly different from
those ofM . leprae-reactive T cells . Thus, in this tuberculoid
leprosy patient, the cytokine secretion profile of CD4+ T
cell clones reactive with nonmycobacterial antigens is not
affected by the disease, but is comparable with the cytokine
secretion patterns of tetanus toxoid and alloreactive T cell
clones from healthy individuals.
The Cytokine Secretion Profile ofT Cell Clonesfrom a Healthy
Individual. Our findings suggest that M. leprae-reactive T
cell clones in these tuberculoid leprosy patients underwent
a selection process resulting in a Th1-like cytokine secretion
profile, characterized by high ratios ofIFN-y to IL4 secre-
tion . To investigate whether this selection process is associated
with inflammatory diseases like tuberculoid leprosy, we tested
four hsp65 peptide 3-13-specific T cell clones from healthy
individualHY In none ofthe supernatants of the hsp65 pep-
tide 3-13-specific T cell clones could 11,4 be detected after
activation (Table 2) . In supernatants oftwo clones, very low
levels of IL5 were measured . In one T cell culture, >100
ng/ml IFN-y was detected, while the other T cell clones
secreted IFN-y in normal or slightly higher levels than normal .
Importantly, IFN-y to IL4 ratios were in the same range
as those ofM. leprae-reactive T cell clones from tuberculoid
leprosy patients . IL-2 andGM-CSF levels were in the normal
range (data not shown) . In addition to hsp65 peptide 3-13-
specific T cell clones from this healthy individual, HY, six
other hsp65 peptide 3-13-specific T cell clones from two
different healthy individuals were tested . The cytokine secre-
tion profile of these hsp65 peptide 3-13-specific clones were
identical to those obtained from clones ofindividualHY (data
Table 2 .
Donor
Cytokine
Clone
Secretion Profile TCell
Restricted by :
Clones Reactive with
Specificity
Mycobacterial hsp
IFN-,y
ng/ml
and Nonmycobacterial
IL-4
pg/ml
Antigensfrom Healthy
IL-5
pg/ml
IndividualHY
Ratio of
IFN--r/IL-4
HY 1 HLA-DR3 [3-131 26.4 ± 0.5 <50 <50 >528
3 HLA-DR3 [3-13] 150.0 ± 12 <50 130 ± 40 >3,000
6 HLA-DR3 [3-131 87.0 ± 1 <50 <50 >1,740
7 HLA-DR3 [3-13] 44 .6 ± 1 <50 205 ± 35 >892
827 HLA-DR3 Tet . tox . 43 .5 ± 1 230 ± 50 530 ± 50 189
HY 15 ND Autoantigen 0.8 ± 0.5 1,435 ± 120 6,325 ± 325 0.6
606 ND Alloantigen 1 .6 ± 1 720 ± 45 ND 2.2
837 ND Alloantigen 28.1 ± 1 3,320 ± 320 5,320 ± 50 8.4included in Fig. 1). As a control for cloning technique and
antigen-related cytokine secretion patterns, we also included
four nonmycobacteria-reactive T cell clones from healthy in-
dividual HY, established in the same manner. These T cell
clones with allo or undefined specificity were capable of
secreting IFN-y, 1174, and 11,5 simultaneously and thus clearly
differed from the mycobacteria-reactive Thl-like cells.
This Thl-like pattern of cytokine secretion found in T cells
from healthy individuals is similar to that of the T cell clones
from tuberculoid leprosy patients, although our data sug-
gest that the patient-derived T cell clones are capable of
producing more IFN-y than the clones and lines from healthy
individuals. Statistical analysis (Mann-Whitney U-Test) com-
paring the IFN-y secretion of hsp65 peptide 3-13-specific
clones from patients with that of healthy controls (Xz =
9.01, and p = 0.002) indicated that at least for reactivity to
this peptide the difference in IFN-,y secretion between pa-
tients and controls is significant. In conclusion, the secretion
of high levels of IFN-T and low to negligible levels of IL4
and IL-5 (Thl-like pattern) seems to be related to the antigen
specificity of T cells per se, irrespective of the health or dis-
ease status of the donor.
Cytokine Secretion Profiles ofT Cell Clones and Lines Reac-
tive with Mycobacterial Proteins Diferentfrom Heat Shock Pro-
teins. So far, all heat shock protein-specific T cell clones ob-
tained from both tuberculoid leprosy patients and healthy
individuals exhibited a Thl-like cytokine secretion profile as
determined by the high IFN-y to 11,4 and IL5 ratios. Al-
though heat shock proteins are major mycobacterial antigens
and strong immunogens, it needed to be emphasized whether
Specificity
Donor
￿
Clone
￿
Restricted by:
￿
(M)
kD
W 5 DR1
￿
14-15
9 DR4(Dw14) 16-23
13 DR4(Dw14) 30/31
15 DR4(Dw14) 30/31
K IIBS DR4(Dw4) 27-29
IVB6 DR4(Dw4) ND
CAA p1517 DR3 41-45
p1518 DR3
￿
57-67
p1510 DR3
￿
<15
vEs TCL* HLA-DR3,5 30/31
Hass TCLPP, HLA-DR3,5 30/31
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the Thl-like cytokine profiles were confined to T cells reac-
tive with heat shock proteins. Therefore, we tested a panel
of T cell clones and polyclonal T cell lines that were gener-
ated against either M. tuberculosis, PPD, or M. leprae. The
specific antigen definition was determined by T cell immu-
noblot analysis and revealed that protein antigens other than
hsp were recognized (Table 3). The M. tuberculosis-reactive
T cell clones (n = 6) were obtained from the synovial fluids
oftwo rheumatoid arthritis patients, whereas M. lepme-reactive
T cell clones (n = 3) and the PPD-reactive polyclonal T cell
lines (n = 2) were derived from three healthy donors. The
T cell clones employed the TCR-ct/0 for recognition of an-
tigen and were positive for the CD4 surface molecule. After
stimulation with antigen, in all T cell cultures IFN-,y could
be detected. The levels varied from normal (5 ng/ml) to very
high (825 ng/ml). In only one of the supernatants, however,
low level of I1,4 (200 pg/ml) could be detected. IIr5 levels,
when tested, did not exceed 350 pg/ml. In those superna-
tants where we tested for IL -2 and/or GM-CSF, normal values
were obtained.
Our results show that mycobacteria-reactive T cells, inde-
pendent of their antigen specificity or the health or disease
status ofthe donor, display a Thl-like cytokine secretion profile.
Interestingly, even in short-term bulk cultures generated by
in vitro restimulation ofPBMC with mycobacteria, this Thl-
like response can easily be detected. We defined this Thl-like
cytokine secretion profile by calculating the ratios of IFN-'Y
to IL-4 levels secreted by the T cells.
The picture emerging from a comparison of the IFN-y
to 11,4 ratios between all mycobacteria-reactive T cells and
Table 3.
￿
Cytokine Secretion Profile of T Cell Clones and Lines Reactive with Mycobacterial Protein Antigens Diferent from hsp
Ratio of
IFN-,y IL-4 IL-5 IFN-y/IL-4
ng/ml pg/ml pg/ml
12.5 ± 1.0
￿
<50
￿
340 ± 65
￿
>250
190.0 ± 9
￿
<50
￿
<50
￿
>3,800
26.0 ± 1
￿
<50
￿
300 ± 85
￿
>520
45.0 ± 14
￿
<50
￿
<50
￿
>900
5.1 ± 1
￿
<50
￿
350 ± 80
￿
>102
40.0 ± 11
￿
<50
￿
170 ± 50
￿
>880
19.8 ± 3
￿
200 ± 45
￿
175 ± 50
￿
>110
26.8 ± 2
￿
<50
￿
<50
￿
>530
25.7 ± 2
￿
<50
￿
<50
￿
>510
26.0 ± 1
￿
<100
￿
ND
￿
>260
825 t 12
￿
<100
￿
ND
￿
>5,000
Donors W and K are rheumatoid arthritis patients. The six M. tuberculosis-reactive T cell clones are derived from the synovial fluid of these patients.
None of the M. tuberculosis protein fractions recognized by these clones comprise hsp. Donors CAA, vEs, and Hass are healthy PPD responders.
p1517, p1518, and p1510 are HLA-DR3-restricted T cell clones, and TCLpd are short-term bulk cultures generated against-M. tuberculosis (PPD),
respectively. TCL pd from these individuals respond predominantly to a secreted non-hsp antigen with M, 30/31 kD.nonmycobacteria-reactive T cells used in this study (Fig. 1),
illustrates the clearcut difference in cytokine secretion profiles
within these groups.
Cytokine Secretion Profile ofM. leprae-reactive T Cell Clones
after Different Modes ofActivation. The effect of mitogenic
stimulation on the cytokine secretion of theseM. hTme-reactive
T cell clones was compared with antigen-specific stimula-
tion. Stimulation for 22 h with either the lectin Con A or
a combination ofan anti-CD3 mAb plus phorbol ester PMA
has been shown to be a powerful cytokine secretion inducer
in T cells (11). The influence of mitogenic stimuli on the
cytokines secretion was studied especiallyin those cases where
IL4 and IL5 release after peptide stimulation was undetect-
able. As shown in Table 4, treatment of T cells with poly-
clonal stimuli did not induce the ability to secrete detectable
levels of IL A or IL5. The levels of IFN-,y released by the
T cell clones varied with different modes of activation, but
the highest values were obtained usingantigen-specific stim-
Six M leprae-reactive T cell clones were stimulated in same experiment with either Con A, anti-CD3 mAb + PMA, or with specific antigen in
the presence of HLA-DR matched APC for 20-24 h, after which the supernatants were tested for cytokine release by the T cells.
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ulation. Thus, the Th1-like cytokine secretion pattern seems
to be an intrinsic property of activated M. leprae-reactive T
cell clones.
The Effect of Different APC on the Cytokine Secretion of
M. leprae-reactive T Cell CloneR1F9. Clone R1F9 was studied
to examine the role ofdifferent sources of APC on the cytokine
secretion pattern. In the mouse, it was shown that the different
CD4+ helper T cell subsets may require different accessory
signals (28-30). We compared the capacity of PBMC (with
monocytes as the major source of APC) and EBVtransformed
B cells to induce cytokine secretion in this representative T
cell clone. As shown in Table 5, both types of APC were
able to induce secretion of IIr2, IFN-'y, and GM-CSF, al-
though differences in the levels of 11,2 and GM-CSF induced
by PBMC or EBVB cells were found. Neither PBMC nor
EBVB cells were able to induce secretion 11,4 and IL5, again
indicating that the cytokine secretion pattern of an activated
T cell clone is an intrinsic property of the clone. Thus, at
Table 4. Cytokine Secretion Profile Is an Intrinsic Property of Activation T Cell Clones
Clone RD Stimulation IFN--y IL-4 IL-5
ng/ml pg/ml pg/ml
R1F9 DR3 Con A 17.4 ± 2 <50 <50
RIF9 DR3 Anti-CD3/PMA 7.0 ± 1 <50 <50
RiF9 DR3 APC + [3-131 1,400.0 ± 42 <50 <50
RiF9 DR3 APC <1.0 <50 <50
R3E10 DR3 Con A 18.6 ± 3 <50 <50
R3E10 DR3 Anti-CD3/PMA 22.5 ± 5 <50 <50
R3E10 DR3 APC + [3-131 77.5 ± 2 <50 <50
R3E10 DR3 APC <1 .0 <50 <50
R5E10 DR3 Con A 12.4 ± 2 <50 <50
R5E10 DR3 Anti-CD3/PMA 5.3 ± 1 <50 <50
R5E10 DR3 APC + [3-131 49.9 ± 6 <50 <50
R5E10 DR3 APC <1 .0 <50 <50
RIF3 DR3 Con A 27.6 ± 3 <50 <50
R1F3 DR3 Anti-CD3/PMA 56.1 ± 3 <50 <50
RIF3 DR3 APC + M. eprae 44.2 ± 3 <50 <50
R1F3 DR3 APC <1 .0 <50 <50
N4H1 DR1 Con A 7.6 ± 1 <50 <50
N4H1 DRI Anti-CD3/PMA 4 .3 ± 1 <50 <50
N4R1 DR1 APC + [412-4251 78.0 ± 2 <50 <50
N4H1 DRI APC <1.0 <50 <50
W2G2 DRI Con A 42 .1 ± 4 <50 <50
W2G2 DRI Anti-CD3/PMA 68 .6 ± 3 <50 <50
W2G2 DR1 APC + [412-4251 1,250.0 ± 56 <50 <50
W2G2 DR1 APC <1.0 <50 <50Clone RIF9 was stimulated with its specific antigen M. leprae hsp65 peptide 3-13 in increasing doses using either irradiated PBMC or EBV-BCL
as APC. The number of T cells (106) and APC (3 x 106) was kept constant . T cells were stimulated in such a manner for 22 h. Supernatants
were tested the presence of IL-2, IFN-.y, IL-4, IL-5, and GM-CSF.
least for this established humanT cell clone, accessory signals
necessary for secretion of IL2, IFN-y, and GM-CSF can be
provided by different types of APC.
Discussion
Several groups have reported that the majority of human
T cell clones established in vitro are able to produce IL2,
IL-4, 1175, IFN-y, and other cytokines after stimulation (11,
31). Those T cell clones were established using different metho-
dologies and had various antigen specificities or no clearly
defined specificities when generated with mitogens like PHA.
No evidence was found in these earlier studies that human
T cell clones can be classified into Thl and Th2, as reported
for mouse helper T cells. In fact, most human T cell clones
analyzed thus far, including many alloreactive, tetanus toxoid,
and Herpes Simplex Virus (HSV)-specific clones, seem to
resemble murine Th0 cells. Recently, human T cell clones
have been described that displayed cytokine secretion profiles
distinct from the Th0 pattern, indicating that also in man
functionally distinct CD4+ T cell subsets may exist (12, 13).
In this report, we describe a group of human T cell clones
with common characteristics that bear close resemblance to
murine Thl cells. The common characteristic ofthese T cell
cones is that they recognize mycobacterial antigens. These
mycobacterium-reactive T cell clones show very high IFN-.y
to IL-4 ratios as compared to T cell clones specific for alloan-
tigen or for tetanus toxoid. It should, however, be noted that
in contrast to what has been observed with murine Thl clones,
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a number of mycobacteria-specific clones do produce IL4 and
11,5, and many of those clones that do not secrete detectable
amounts of IL4 and IIr5 proteins do express 1174 and 1175
transcripts, as determined with the highly sensitive PCR
method (data not shown). Nevertheless, the ratios ofthe secre-
tion of IFN-y to IL4 of these 114- and IIr5-producing T
cell clones that are reactive with mycobacterial antigens clearly
sets them apart from the Th0-like tetanus toxoid and
alloantigen-specific clones.
The mycobacteria-reactive clones recognized different an-
tigens. T cell clones isolated from three different tuberculoid
leprosy patients recognized hsp65 and hsp70. The hsp-65-
specific clones recognized different T cell epitopes in the con-
text of HLA-DR1, DR2, or DR3. The Thl-like pattern of
cytokine secretion was, however, not restrictedto T cell clones
reactive with mycobacterial hsp. Several T cell clones, iso-
lated from the synovial fluid ofpatients suffering from rheu-
matoid arthritis that were reactive with different mycobac-
terial proteins not belonging to the hsp family, also showed
a Thl-like cytokine secretion profile. Furthermore, this Thl-
like pattern was not a consequence of a particular disease of
the donors from whom these T cell clones were isolated. First,
T cell clones from a tuberculoid leprosy patient that were
specific for nonmycobacterial antigens like tetanus toxoid and
alloantigens, secreted levels of IFN-y, IL4, and IL-5 com-
parable to those secreted by clones described so far (11, 13,
31), with similar antigen specificities, including tetanus toxoid,
alloantigens, Candida albicans, or HSV isolated from healthy
individuals. Second and more importantly, T cell clones reactive
Table 5. Effect of Different APC on the Cytokine Secretion Profile
Clone APC [3-13] IL-2 IFN-'Y IL-4 IL-5 GM-CSF
hg/ml U/ml ng/ml pg/ml pg/ml "g/ml
R1F9 MNC 0.001 0.0 15.8 <50 <50 15.9
MNC 0.01 0.0 31 .2 <50 <50 18.8
MNC 0.1 0.0 51 .7 <50 <50 2.1
MNC 0.3 0.0 96.3 <50 <50 1.7
MNC 1.0 0.2 211.0 <50 <50 6.6
MNC 10.0 0.5 750.0 <50 <50 8.3
MNC 30.0 1.0 1,300.0 <50 <50 13.2
R1F9 EBV-BCL 0.001 0.0 <1 .0 <50 <50 1.9
EBV-BCL 0.01 0.0 3.9 <50 <50 1.6
EBV-BCL 0.1 0.2 5.5 <50 <50 2.3
EBV-BCL 0.3 0.3 40.0 <50 <50 3.4
EBV-BCL 1.0 3.7 140.0 <50 <50 13.9
EBV-BCL 3.0 9.3 610.0 <50 <50 28.6
EBV-BCL 10.0 17.4 1,100.0 <50 <50 58.2
EBV-BCL 30.0 33.6 1,600.0 <50 <50 98.1with mycobacterial antigens, isolated from healthy subjects,
secreted IFN-y but almost no 1174 and IL5. It seems, there-
fore, that mycobacteria select for CD4+ T cells that produce
IFN-y, but no or disproportionally low levels of 11'4 and
IL-5. This cytokine secretion profile was observed with T cell
clones reactive with mycobacteria regardless of the antigen
recognized, the HLA-DR restriction element, and the TCR
Vii gene segment usage, or whether or not the donor suffered
from a mycobacterium-inflicted disease. In addition, this Thl-
like pattern of cytokine secretion was an intrinsic property
of the mycobacterium-reactive clones, since this pattern was
not affected by the way the clones were stimulated in vitro.
It is likely but not sure that the Thl-like T cell clones are
representative for the T cells that are involved in the cellular
immune response against mycobacter a. It needs to be demon-
strated that, for example, T cells present in lesions inflicted
byM. leprae produce IFN-y but not 114. Thl cells have been
shown to protect mice against lethal infections with the in-
tracellular parasite Leishmania donovani (32). The mechanism
of protection is not entirely clear but involves IFN-y. Injec-
tion of anti-IFN-y antibodies abrogates resistance of C3H
mice to infection with L. major (33). On the other hand,
IL-4 has an adverse effect on protection against Leishmania
infection, since anti-IL-4 mAbs can cure susceptible BALB/c
mice infected with L. major (34). IFN-y induces killing of
the obligatory intracellular amastigote form of the parasite
(35-37) . IL-4 seems to inhibit this IFN-y-induced killing ac-
tivity of macrophages (38). It is likely, therefore, that IFN-
y-induced macrophage killing activity is involved in the pro-
tection against infections with Leishmania, although there
is evidence for other T cell-dependent mechanisms that play
a role in this protection (33). Mycobacteria are obligatory
intracellular organisms, and similar mechanisms may be im-
plicated in containment of mycobacterial and Leishmania in-
fections. In that case, Thl-like cells may pose a distinct ad-
vantage above ThO- or Th2-like cells in protection against
mycobacterial infections. However, in tuberculoid leprosy, there
is evidence for the occurrence of pathological immune re-
sponses against M. leprae. This disease is characterized by the
occurrence of granulomatous skin lesions with heavy infiltra-
tion of CD4+ T lymphocytes around activated macro-
phages, usually accompanied by nerve destruction. In these
lesions, few ifany bacilli can be found, indicating a successful
eradication of the mycobacteria. There is, however, evidence
that the prominent nerve damage is the result of this cellular
immune response against M. leprae (14). Thus, the Thl-like
cells in tuberculoid leprosy patients may also be involved in
some of the immunopathological manifestations. In this re-
spect, it is perhaps relevant that T cell clones specific for the
hsp65 peptide 3-13 isolated from a tuberculoid leprosy pa-
tient secreted much more IFN-y than T cell clones with ex-
actly the same antigen specificity (hsp65 peptide 3-13) iso-
lated from healthy individuals. This suggests that a feedback
mechanism is operating in tuberculoid leprosy patients that
results in an enhanced capacity to produce IFN-y. It is
presently unknown how the balance between a normal pro-
tective immune response and a immunopathological immune
response is disturbed in tuberculoid leprosy.
Thus far, it is not knownhow T cells with different cytokine
secretion patterns are selected. Studies that address the ques-
tion how naive CD4+ T cells mature to memory cells may
help to unravel the mechanism underlying the selective in-
duction of distinct helper T cell subsets. It has been reported
that murine CD4+ T cells that were considered function-
ally immature are able to produce 11,2 but almost no IFN-y
or IL4 (39, 40). Likewise, in man, CD45RA+ T cells, con-
sidered to be naive, and cord blood T cells, which should
be immunologically immature, are able to produce IL2 and
perhaps low levels of IFN-y but no IL4 (41-45). On the
other hand, CD45RO+ T cells, thought to include memory
T cells, do produce IL2, IFN-y, and IL4 after activation in
vitro (41, 46). These findings suggest that the ability to pro-
duce IFN-y, IL4, and several other cytokines is acquired upon
maturation of naive to memory T cells (45). Mosmann and
Coffman (47) have proposed two mechanisms for matura-
tion of TH1 and Th2 cells. One postulates that Thl and TH2
cells develop from a common precursor ThO cell that is able
to produce all cytokines simultaneously. Based on the findings
with naive and memory T cells discussed above, this precursor
ThO cell should be a memory cell that has already been primed
with antigen. In that case, it should be assumed that tetanus
toxoid-specific clones are arrested in a ThO phase, while T
cells reactive with mycobacterial antigens mature further to
Thl-like cells. Another perhaps more plausible hypothesis is
that Thl, Th2, and THO cells mature from naive T cells in-
dependently. Insight in the mechanism of priming of naive
T cells with mycobacteria may provide an answer to the ques-
tion why T cells reactive with mycobacteria develop into Thl-
like cells.
The data presented here indicate that mycobacteria select
for a certain immune response. It would be interesting to
know whether other pathogenic bacteria can also induce matu-
ration of distinct subsets of CD4+ T cells.
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